These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26042736)

  • 21. Drug Target Identification and Validation: Global Pharmaceutical Industry Experts on Challenges, Best Strategies, Innovative Precompetitive Collaboration Concepts, and Future Areas of Industry Precompetitive Research and Development.
    Bergauer T; Ruppert T; Essioux L; Spleiss O
    Ther Innov Regul Sci; 2016 Nov; 50(6):769-776. PubMed ID: 30231745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racing to define pharmaceutical R&D external innovation models.
    Wang L; Plump A; Ringel M
    Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organizing for innovation: towards successful translational research.
    West W; Nightingale P
    Trends Biotechnol; 2009 Oct; 27(10):558-61. PubMed ID: 19683820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new chapter in innovation.
    Holmes D
    Nature; 2016 May; 533(7602):S54-5. PubMed ID: 27167390
    [No Abstract]   [Full Text] [Related]  

  • 25. Professional translational research: a new hybrid paradigm in early drug discovery.
    Nussbaumer P; Klebl B
    Future Med Chem; 2015; 7(14):1879-89. PubMed ID: 26420644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of patent sharing in neglected disease drug discovery.
    Edlin C
    Future Med Chem; 2011 Sep; 3(11):1331-4. PubMed ID: 21879838
    [No Abstract]   [Full Text] [Related]  

  • 27. Is Open Science the Future of Drug Development?
    Shaw DL
    Yale J Biol Med; 2017 Mar; 90(1):147-151. PubMed ID: 28356902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Industry-funded dermatologic research within academia in the United States: fiscal and ethical considerations.
    Blank IH
    J Invest Dermatol; 1992 Mar; 98(3):265-8. PubMed ID: 1545134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation.
    Stewart SR; Barone PW; Bellisario A; Cooney CL; Sharp PA; Sinskey AJ; Natesan S; Springs SL
    Clin Pharmacol Ther; 2016 Dec; 100(6):647-653. PubMed ID: 27617845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lost opportunities.
    Phan P; Wong D
    Nature; 2017 Dec; 552(7683):S18. PubMed ID: 29220004
    [No Abstract]   [Full Text] [Related]  

  • 31. The COVID-19 Innovation System.
    Sampat BN; Shadlen KC
    Health Aff (Millwood); 2021 Mar; 40(3):400-409. PubMed ID: 33539184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerating target discovery using pre-competitive open science-patients need faster innovation more than anyone else.
    Low E; Bountra C; Lee WH
    Ecancermedicalscience; 2016; 10():ed57. PubMed ID: 27594912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Open Access Could Transform Drug Discovery: A Case Study of JQ1.
    Arshad Z; Smith J; Roberts M; Lee WH; Davies B; Bure K; Hollander GA; Dopson S; Bountra C; Brindley D
    Expert Opin Drug Discov; 2016; 11(3):321-32. PubMed ID: 26791045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Professional medical associations and the opportunity to promote breakthrough biomedical innovation.
    Xu S; Xu RS; Breslin J; Raff AB; Garibyan L; Sunshine JC; Ju WD
    Drug Discov Today; 2018 Aug; 23(8):1453-1456. PubMed ID: 29391260
    [No Abstract]   [Full Text] [Related]  

  • 35. Accessing external innovation in drug discovery and development.
    Tufféry P
    Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
    Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
    Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Joint European Compound Library: boosting precompetitive research.
    Besnard J; Jones PS; Hopkins AL; Pannifer AD
    Drug Discov Today; 2015 Feb; 20(2):181-6. PubMed ID: 25205347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Public-private partnerships to revitalize psychiatric drug discovery.
    Brady LS; Potter WZ
    Expert Opin Drug Discov; 2014 Jan; 9(1):1-8. PubMed ID: 24308355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four disruptive strategies for removing drug discovery bottlenecks.
    Ekins S; Waller CL; Bradley MP; Clark AM; Williams AJ
    Drug Discov Today; 2013 Mar; 18(5-6):265-71. PubMed ID: 23098820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patent-free pact pushes the boundaries of precompetitive research.
    Dolgin E
    Nat Med; 2014 Jun; 20(6):564-5. PubMed ID: 24901552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.